The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease
- PMID: 2215576
- DOI: 10.1056/NEJM199010183231602
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease
Abstract
Background: A high incidence of hypertension (50 to 75 percent) occurs early in the course of autosomal dominant polycystic kidney disease. Cyst enlargement, causing bilateral renal ischemia and subsequent release of renin, is proposed as the cause of this form of hypertension.
Methods: To investigate this hypothesis, we measured plasma renin activity and aldosterone concentrations during short-term and long-term converting-enzyme inhibition in 14 patients with hypertension due to polycystic kidney disease, 9 patients with essential hypertension, 11 normotensive patients with polycystic kidney disease, and 13 normal subjects. The groups were comparable with respect to age, sex, body-surface area, degree of hypertension, sodium excretion, and renal function.
Results: During the short-term study, the mean (+/- SE) plasma renin activity was significantly higher in the hypertensive patients with polycystic kidney disease than in the patients with essential hypertension, in the supine (0.36 +/- 0.06 vs. 0.22 +/- 0.06 ng per liter.second, P = 0.05) and upright positions (1.03 +/- 0.14 vs. 0.61 +/- 0.08 ng per liter.second, P less than 0.03) and after converting-enzyme inhibition (1.97 +/- 0.28 vs. 0.67 +/- 0.17 ng per liter.second, P less than 0.0006). The mean arterial pressures measured in the supine and upright positions and the plasma aldosterone concentrations measured in the upright position were significantly higher in the normotensive patients with polycystic kidney disease than in the normal subjects. After six weeks of converting-enzyme inhibition, renal plasma flow increased (P less than 0.005), and both renal vascular resistance (P less than 0.007) and the filtration fraction (P less than 0.02) decreased significantly in the hypertensive patients with polycystic kidney disease but not in the patients with essential hypertension.
Conclusions: The renin-angiotensin-aldosterone system is stimulated significantly more in hypertensive patients with polycystic kidney disease than in comparable patients with essential hypertension. The increased renin release, perhaps due to renal ischemia caused by cyst expansion, probably contributes to the early development of hypertension in polycystic kidney disease.
Comment in
-
The renin-angiotensin system and polycystic kidney disease.N Engl J Med. 1991 Mar 14;324(11):775-6. N Engl J Med. 1991. PMID: 1997847 No abstract available.
-
Renin--from beginning to end.N Engl J Med. 1990 Oct 18;323(16):1136-7. doi: 10.1056/NEJM199010183231609. N Engl J Med. 1990. PMID: 2215582 No abstract available.
Similar articles
-
Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents.N Engl J Med. 1991 May 9;324(19):1305-11. doi: 10.1056/NEJM199105093241902. N Engl J Med. 1991. PMID: 2017226
-
Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.Am J Vet Res. 1997 May;58(5):535-40. Am J Vet Res. 1997. PMID: 9140564 Clinical Trial.
-
Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.Am J Vet Res. 1999 Dec;60(12):1516-25. Am J Vet Res. 1999. PMID: 10622161 Clinical Trial.
-
Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.J Am Soc Nephrol. 2009 Sep;20(9):1888-93. doi: 10.1681/ASN.2008080882. Epub 2009 Aug 20. J Am Soc Nephrol. 2009. PMID: 19696226 Review.
-
Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.Expert Rev Cardiovasc Ther. 2004 May;2(3):369-74. doi: 10.1586/14779072.2.3.369. Expert Rev Cardiovasc Ther. 2004. PMID: 15151483 Review.
Cited by
-
Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F349-57. doi: 10.1152/ajprenal.00478.2014. Epub 2014 Dec 23. Am J Physiol Renal Physiol. 2015. PMID: 25537744 Free PMC article.
-
Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.Physiology (Bethesda). 2015 May;30(3):195-207. doi: 10.1152/physiol.00032.2014. Physiology (Bethesda). 2015. PMID: 25933820 Free PMC article. Review.
-
Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes.J Diabetes Investig. 2024 Jan;15(1):26-33. doi: 10.1111/jdi.14120. Epub 2023 Dec 11. J Diabetes Investig. 2024. PMID: 38078509 Free PMC article.
-
Autosomal dominant polycystic kidney disease: new role for ultrasound.Eur Radiol. 2019 Nov;29(11):5991-5998. doi: 10.1007/s00330-019-06238-0. Epub 2019 Apr 26. Eur Radiol. 2019. PMID: 31028448
-
Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease.Physiol Rep. 2015 May;3(5):e12405. doi: 10.14814/phy2.12405. Physiol Rep. 2015. PMID: 25999403 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical